Exicure Inc

NASDAQ:XCUR  
0.51
-0.04 (-7.16%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)44.69M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.25 Million
Adjusted EPS-$0.15
See more estimates
10-Day MA$0.65
50-Day MA$1.09
200-Day MA$1.57
See more pivots

Exicure Inc Stock, NASDAQ:XCUR

2430 North Halsted Street, Suite 410, Chicago, Illinois 60614
United States of America
Phone: +1.847.673.1700
Number of Employees: 63

Description

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.